Projects
Explore
News
Events
Weekly
Search
Product
Pricing
About Us
Sign in
Chemical industry plants and projects, tracked since 2013
Product
Pricing
About Us
Sign in
Projects
Explore
News
Events
Weekly
All news
(page 12)
17 September 2026
Novo Nordisk: Denecimig tolerated after direct switch from emicizumab in FRONTIER5
Phase 3b switch study shows denecimig well tolerated after direct switch from emicizumab; pen injector preferred and thrombin generation rose to normal without excess clotting.
17 September 2026
MAIRE's Tecnimont wins FEED and OBCE contract for Asian petrochemical project
FEED plus Open Book Cost Estimation for an Asian petrochemical plant; scope covers engineering package, technical requirements and cost estimate. FEED due early 2028; EPC depends on client's FID.
17 September 2026
Ren‑Gas signs H2PPAs with Helen and second supplier for Tampere e‑methane plant
Long-term H2PPAs secure physical renewable power and Guarantees of Origin for RFNBO-compliant hydrogen, enabling flexible e‑methane production and advancing the project's FID.
17 September 2026
Roche: CELESTIMO Phase III shows PFS benefit for Lunsumio plus lenalidomide
Interim analysis shows a significant progression‑free survival benefit versus rituximab+lenalidomide in second‑line or later relapsed/refractory follicular lymphoma; safety as expected.
17 September 2026
Arkema sues HighChem in Japan over HFO-1233zd(E) patents
Seeks injunction on import and sale of HFO-1233zd(E), citing two Japanese patents covering blowing agents for thermosetting foams and refrigerant heat-transfer fluids.
17 September 2026
WACKER REFOCUS: pursue GDP+ growth, 15% EBITDA margin and ROCE >10%
Selective growth in electronics, healthcare and mobility; €300–€400m annual investment; PACE to save >€300m/year from 2028; Net Zero by 2045.
17 September 2026
Roche: Lunsumio plus lenalidomide improves PFS in relapsed/refractory follicular lymphoma
Phase III CELESTIMO interim analysis showed a statistically significant, clinically meaningful PFS benefit versus rituximab+lenalidomide; OS immature; safety consistent with known profiles.
17 September 2026
Sinopec's 112 MW Zhongyuan Wind Project Generates 430 Million kWh
Largest oilfield wind project has produced 430 million kWh, averages 250 million kWh/year, and supplies about a quarter of the local headquarters' electricity demand.
17 September 2026
SkyNRG CEO Maarten van Dijk to step down
Will leave the CEO role on 31 December 2026 and support handover through Q1 2027; Board has appointed Egon Zehnder to run the external CEO search.
17 September 2026
EnergyPathways and Hycamite advance low‑carbon hydrogen and graphite plant at Port of Barrow
Plans target 20,000 t/yr hydrogen and ~60,000 t/yr graphite using methane decomposition; ties into MESH long‑duration storage to capture surplus wind power and cut emissions.
17 September 2026
NEDO and partners achieve 85% ammonia co‑firing in naphtha cracking furnace
New ammonia-fired burners enabled a world-class 85% heat-input co‑firing rate in a test naphtha cracking furnace while keeping NOx comparable to current furnaces.
16 September 2026
Moeve brings Hy24 and COFIDES into Onuba phase of Andalusian Green Hydrogen Valley
First phase includes a 300 MW electrolyser (>€1bn capex), ~45,000 t H2/yr and ~250,000 t CO2 avoided; received €304m public funding and reached FID.
16 September 2026
European Commission raises objections to MMG's proposed acquisition of Anglo American's nickel business
Regulator flags risk that the deal could curtail low-carbon ferronickel supply into Europe, raising stainless-steel production costs and weakening resilience.
16 September 2026
CATL licenses battery-pack technology to BME for Egyptian 1 GWh plant
Initial 1 GWh pack plant for heavy-duty vehicles with planned expansion to 5 GWh and addition of passenger EV packs and solar/wind energy storage; licensor to supply cells, tech and training.
16 September 2026
Genentech: Lunsumio plus lenalidomide improves PFS in Phase III CELESTIMO for relapsed/refractory follicular lymphoma
Phase III CELESTIMO showed a statistically significant, clinically meaningful progression‑free survival benefit for Lunsumio plus lenalidomide versus rituximab plus lenalidomide in relapsed/refractory FL after ≥1 prior therapy.
16 September 2026
Toray wins RO membrane order for Changi NEWater Factory 3
Low‑fouling RO elements ordered for a 50 million gallons-per-day wastewater reclamation plant in Changi, with completion targeted in 2028.
16 September 2026
Air Products wins long-term contract to supply high-purity gases for U.S. semiconductor expansion
Second recent semiconductor supply win; $250M Arizona investment to build PRISM hydrogen units, CO2 purification and helium/hydrogen/CO2 bulk and pipeline systems with phased start-up.
16 September 2026
Técnicas Reunidas wins FEED for 1 Mt/y green ammonia plant in South Africa
FEED covers electrolyzers, ASUs, green ammonia loop, desalination, >100,000 t storage and port pipelines; FEED may convert to EPC subject to FID; projected capex ~$1.8bn.
16 September 2026
Symrise completes Floral Concept acquisition to expand Premium Naturals
A French premium naturals house will join the Fragrance division and form a Naturals cluster with Maison Lautier 1795 in Pays de Grasse; business continuity prioritized.
16 September 2026
SOCAR acquires 10% stake in Baleine project from Eni
Adds a 10% interest in the Baleine offshore field; discovered 2021, production began 2023. Project is billed as Africa’s first net‑zero offshore oil and gas development.
16 September 2026
Heidelberg Materials to close Ranville cement plant
Closure of Ranville cement site after weak French demand; 87 employees affected; shift to lower‑clinker, higher‑value cement to cut CO₂; €650m invested in other French sites.
16 September 2026
Neste and United Airlines extend SAF supply deals at Schiphol and Chicago O’Hare
Deliveries began June–Aug 2026 in Amsterdam and run July 2026–June 2027 in Chicago; SAF comes from waste fats and used cooking oil and can be blended up to 50% with jet fuel.
16 September 2026
Chugai: FoundationOne CDx approved as companion diagnostic for tovorafenib in BRAF‑altered/fusion glioma
Approval allows FoundationOne CDx to detect BRAF V600 alterations and BRAF fusion genes to guide tovorafenib treatment in glioma and expands companion indications to nine cancer types.
16 September 2026
OMV confirms Essar discovery in Libya's Sirte Basin
Commercially viable Essar discovery holds up to 45 million barrels and could reach ~6,000 b/d; proximity to infrastructure enables rapid, cost-efficient development.
16 September 2026
EnviTec Biogas advances three biomethane projects in Germany
Three biogas-to-biomethane upgrades across Germany, capacities 200–475 Nm³/h now, Friesoythe expandable to 600 Nm³/h; Delbrück first feed-in targeted for November.
16 September 2026
Covestro opens Leverkusen pilot plant for chemical recycling of Vulkollan
Pilot plant for chemical recycling of high-performance elastomers in Leverkusen; targets >90% material recovery and up to two-thirds lower carbon footprint vs virgin material.
16 September 2026
Covestro opens Leverkusen pilot plant for chemical recycling of Vulkollan
Pilot plant scales a chemical recycling route for high‑performance Vulkollan elastomers, enabling >90% mass recovery and cutting carbon footprint by up to two thirds.
16 September 2026
Worley completes FEEDs for INPEX Abadi LNG and CCS in Indonesia
FEED covered two offshore packages including ~150 km subsea, gas export and CCS pipelines; project targets ~9.5 Mtpa LNG and supports Indonesia's energy security and net-zero 2060 goals.
16 September 2026
dsm-firmenich opens Jakarta office and expands Karawang manufacturing
New Jakarta Creative Center consolidates labs and co-creation spaces; Karawang expansion adds drying and blending capabilities and reduces CO₂ via electrification and heat recovery.
16 September 2026
H2APEX and Lhyfe expand RFNBO supply pact for Germany
Adds up to 100 t/year of RFNBO hydrogen for two years to meet mobility and industrial demand in Germany amid a fast-ramping market.
← Previous
Next →